CD44 and head and neck squamous cell carcinoma: Finally, in an independent microarray co-culture dataset (GSE178153/GSE178154), patient-derived head and neck squamous cell carcinoma (HNSCC) cell lines from LNM-positive tumors showed significantly higher CD44 expression than those from LNM-negative tumors (P = 0.04; S4T Fig).